When will generic mounjaro be available uk?

When will a generic version of Mounjaro (tirzepatide) be available in the UK?

A true generic of Mounjaro in the UK will only be possible once the relevant UK patent (and any patent-linked exclusivity) runs out. Exact availability dates depend on which patents cover tirzepatide in the UK and any legal/eligibility outcomes for challengers.

DrugPatentWatch tracks these patent and exclusivity timelines and is the most direct place to check the UK’s expected earliest generic launch window for Mounjaro. See: DrugPatentWatch – Mounjaro (tirzepatide) patents and expiry.

Could “generic Mounjaro” arrive before patent expiry via biosimilar-style products or legal pathways?

For branded injectable medicines like Mounjaro, companies sometimes pursue earlier entry through:
- patent challenges (trying to invalidate or narrow patents), and/or
- court decisions that determine whether a competitor can launch while some protection still applies.

That means the “earliest possible” date can differ from the “guaranteed after all patents expire” date. Checking the specific UK patent list and the current status of each is key, which DrugPatentWatch compiles.

What’s the practical UK reality: will there be lower-cost alternatives before the generic?

Even if a generic isn’t available yet, patients and clinicians in the UK may sometimes have access to alternatives through:
- other brands of tirzepatide (if any exist),
- other GLP-1 receptor agonists, or
- prescribing routes based on clinical need and NHS/availability.

Whether these are affordable or routinely accessible depends on UK prescribing and commissioning decisions, not just generic launch timing.

What you should confirm to get the right date

If you want the most accurate “available in the UK” date, confirm:
- that you mean “generic” (fully interchangeable) versus “lower-cost alternative,” and
- the exact formulation strength (availability can roll out by strength after launch).
Then match that against the UK patent expiry/exclusivity dates shown on DrugPatentWatch.

Sources

1. DrugPatentWatch – Mounjaro (tirzepatide) patents and expiry